CT Coordinating Committee: Difference between revisions

From QIBA Wiki
Jump to navigation Jump to search
mNo edit summary
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
Co-Chairs: Andrew J. Buckler, MS; Rudresh Jarecha, MBBS, DNB, DMRE; James L. Mulshine, MD
 
<br />RSNA Staff Support: Julie Lisiecki 
Co-Chairs: Andrew J. Buckler, MS, PhD; Rudresh Jarecha, MBBS, DNB, DMRE; James L. Mulshine, MD
 
* [http://tinyurl.com/QIBA-CT-CC-Roster '''Roster''']
* [http://tinyurl.com/QIBA-CT-CC-Roster '''Roster''']


Line 16: Line 17:
::* CT Small Lung Nodule Biomarker Committee - [page: https://qibawiki.rsna.org/index.php/CT_Small_Lung_Nodule_Biomarker_Ctte]   
::* CT Small Lung Nodule Biomarker Committee - [page: https://qibawiki.rsna.org/index.php/CT_Small_Lung_Nodule_Biomarker_Ctte]   
::* CT Angiography Biomarker Committee - [page: https://qibawiki.rsna.org/index.php/CT_Angiography_Biomarker_Ctte]
::* CT Angiography Biomarker Committee - [page: https://qibawiki.rsna.org/index.php/CT_Angiography_Biomarker_Ctte]
==Meetings==
* Zoom calls are held Quarterly. Please contact RSNA Staff for details.

Latest revision as of 17:07, 17 January 2024


Co-Chairs: Andrew J. Buckler, MS, PhD; Rudresh Jarecha, MBBS, DNB, DMRE; James L. Mulshine, MD

Scope

The CT Coordinating Committee is responsible for:

  • Monitoring and coordinating the activities of CT Biomarker Committees
  • Considering and proposing new candidate Biomarker Committees to the Steering Committee
  • Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
  • Approving for publication Biomarker Profiles developed by the CT Biomarker Committees